Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Berger JS, Katona BG, Jones WS, Patel MR, Norgren L, Baumgartner I, Blomster J, Mahaffey KW, Held P, Millegård M, Heizer G, Reist C, Fowkes FG, Hiatt WR. Berger JS, et al. Among authors: fowkes fg. Am Heart J. 2016 May;175:86-93. doi: 10.1016/j.ahj.2016.01.018. Epub 2016 Jan 28. Am Heart J. 2016. PMID: 27179727 Free article. Clinical Trial.
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial.
Kansal A, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FG, Katona B, Mahaffey KW, Norgren L, Hiatt WR, Patel MR, Jones WS. Kansal A, et al. Among authors: fowkes fg. Circ Cardiovasc Interv. 2019 Oct;12(10):e008069. doi: 10.1161/CIRCINTERVENTIONS.119.008069. Epub 2019 Oct 4. Circ Cardiovasc Interv. 2019. PMID: 31581789 Clinical Trial.
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.
Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR. Rymer JA, et al. Among authors: fowkes fg. J Am Heart Assoc. 2020 Oct 20;9(19):e016573. doi: 10.1161/JAHA.120.016573. Epub 2020 Sep 13. J Am Heart Assoc. 2020. PMID: 32924754 Free PMC article. Clinical Trial.
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Rymer JA, Mulder H, Narcisse DI, Rockhold F, Hiatt WR, Fowkes FG, Baumgartner I, Berger JS, Katona BG, Mahaffey K, Norgren L, Blomster JI, Jones WS, Patel MR. Rymer JA, et al. Among authors: fowkes fg. Circ Cardiovasc Interv. 2020 Oct;13(10):e009326. doi: 10.1161/CIRCINTERVENTIONS.120.009326. Epub 2020 Oct 12. Circ Cardiovasc Interv. 2020. PMID: 33040584 Free article. Clinical Trial.
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.
Reynolds RM, Strachan MW, Labad J, Lee AJ, Frier BM, Fowkes FG, Mitchell R, Seckl JR, Deary IJ, Walker BR, Price JF; Edinburgh Type 2 Diabetes Study Investigators. Reynolds RM, et al. Among authors: fowkes fg. Diabetes Care. 2010 Apr;33(4):714-20. doi: 10.2337/dc09-1796. Epub 2010 Jan 22. Diabetes Care. 2010. PMID: 20097784 Free PMC article.
349 results